Pharming Group N.V.
PHAR | NASDAQ
$12.23
+$0.10 (+0.82%)
At close: Oct 30, 2026, 4:00 PM ET
$12.23
$0.00 (0.00%)
After-hours:
Oct 30, 2026, 7:30 PM ET
Fiscal Quarter Period Ending | Q3 2026 Sep 30, 2026 | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | 22.38M | 3.04M | -4.75M | 4.8M | 12.76M | 7.08M | -11.79M | 6.68M | 1.51M | -60K | -16.62M | -2.03M | 3.31M | 3.39M | -16.67M | -18.08M | 9.28M | 19.56M | 4.23M | 2.06M | -417.7K | 7.35M | 12.79M |
Depreciation & Amortization | 2.77M | 3.04M | 3.12M | 3.21M | 2.73M | 2.7M | 2.58M | 7.7M | 2.74M | -293K | 5.92M | 7.56M | 2.9M | 3.16M | 2.31M | 6.97M | 1.95M | 2.07M | 2.19M | 12.71M | 2.34M | 2.46M | 2.06M |
Stock-Based Compensation | n/a | 3.35M | 3.23M | 4.51M | 3.2M | 3.48M | 2.58M | 2.64M | 2.92M | 3.26M | 2.43M | 3.32M | 1.97M | 2.41M | 1.56M | 1.87M | 1.64M | 1.81M | 1.07M | n/a | n/a | 1.89M | 1.91M |
Other Working Capital | -1.06M | -16.86M | 5.1M | 11.91M | 5.14M | 862K | -2.88M | -7.09M | 6.56M | 7.13M | -9.39M | 7.57M | 3.2M | 6.34M | -1.09M | 11.82M | -2.08M | 4.18M | -1.67M | 1 | -1 | -262.19K | -4.33M |
Other Non-Cash Items | 14.33M | -3.97M | -81K | -1.12M | 2.3M | -124K | 5.44M | -604K | -4.78M | -6.84M | 1.68M | 4.12M | -83K | -19.78M | 2.23M | 10.26M | -2.66M | -17.87M | -1.46M | -245.25K | -1.69M | 4.93M | -7.73M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -6.93M | -18.14M | 445K | -685K | 11.04M | -1.39M | 1.42M | -7.09M | 7.35M | -9.29M | -1.05M | -1.38M | -4.56M | 1.2M | -12.21M | 4.21M | 2.4M | -1.57M | -5.42M | 938.46K | 2.98M | -7.28M | -1.97M |
Operating Cash Flow | 32.55M | -12.68M | 1.95M | 10.71M | 32.03M | 11.74M | 232K | 9.33M | 9.74M | -13.22M | -7.65M | 11.58M | 3.53M | -9.62M | -22.79M | 5.24M | 12.62M | 4M | 609K | 15.46M | 3.21M | 9.35M | 7.06M |
Capital Expenditures | -279.95K | -82.45K | -238K | -269K | -70K | -128K | -288K | -136K | -366K | -214K | -80K | -331K | -147K | -771K | -215K | -315K | -104K | -1.18M | -375K | -3.26M | -2M | -4.75M | -2.96M |
Cash Acquisitions | n/a | n/a | n/a | -8K | -302K | -18K | -57.89M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -84K | -194K | 7.58M | n/a | n/a | n/a | -385.68K | 398K |
Purchase of Investments | 54.89K | 272.16K | -102.65M | -2K | n/a | n/a | n/a | -62.07M | -109.8M | -17.68M | -94.78M | -150.11M | -144.55M | n/a | n/a | n/a | n/a | n/a | n/a | 5.22K | -4.57M | n/a | n/a |
Sales Maturities Of Investments | -9.69K | -48.06K | 18.12M | 235K | 23K | 17.1M | 67.87M | 52.41M | 114.51M | 56.25M | 95.52M | 146.36M | 86.45M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | 549 | n/a | -1K | n/a | n/a | n/a | n/a | n/a | -1.97M | n/a | 176K | 23K | 21.08M | n/a | n/a | n/a | -1K | n/a | -0.33 | -1 | n/a | n/a |
Investing Cash Flow | -234.76K | 141.66K | -84.76M | -45K | -349K | 16.96M | 9.69M | -9.79M | 4.35M | 36.39M | 664K | -3.91M | -58.23M | 20.31M | -215K | -399K | -298K | 6.39M | -375K | -6.08M | -7.42M | -5.13M | -2.57M |
Debt Repayment | n/a | -919K | -12.98M | -1.37M | -1.1M | -1.07M | -715K | -1.52M | -1.19M | -30.89M | -1.03M | -1.28M | -1.01M | -1.26M | -1.31M | -926K | -791K | -787K | -807K | n/a | n/a | -1.06M | -554K |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -1.01M | -92.37K | -125K | -2.84M | -2.25M | -2.74M | -6.25M | -2.78M | -266K | 2.59M | -1.44M | 259K | 6.25M | -1.37M | -2.01M | 47K | -1.95M | 48K | -2.1M | -706.9K | -825.32K | -24.47M | -2.5M |
Financial Cash Flow | -406.35K | 208.63K | -9.22M | 1.04M | 9.93M | -2.76M | -6.72M | -2.2M | -1.43M | -28.3M | -2.47M | -1.02M | 5.24M | -2.63M | -2.63M | 278K | -1.92M | -451K | -2.89M | -232.6K | -461.02K | -22.37M | -2.38M |
Net Cash Flow | 31.28M | 105.18M | -92.93M | 12.94M | 40.28M | 32M | 5.15M | -5.72M | 13.52M | -4.75M | -9.85M | 7.09M | -50.37M | 7.59M | -22.56M | 18.64M | -1.26M | 290K | -2.25M | 7.85M | -4.99M | -20.83M | 1.47M |
Free Cash Flow | 32.27M | -12.77M | 1.71M | 10.44M | 31.96M | 11.62M | -56K | 9.2M | 9.38M | -13.44M | -7.73M | 11.25M | 3.38M | -10.39M | -23M | 4.92M | 12.51M | 2.82M | 234K | 12.2M | 1.21M | 4.6M | 4.1M |
Adj. Free Cash Flow | 32.27M | -16.12M | -1.51M | 5.93M | 28.75M | 8.14M | -2.63M | 6.55M | 6.46M | -16.7M | -10.15M | 7.93M | 1.42M | -12.8M | -24.56M | 3.05M | 10.87M | 1.01M | -836K | 12.2M | 1.21M | 2.71M | 2.19M |
Maintenance CapEx | -279.95K | -82.45K | -238K | -269K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -178.79K | -215K | -315K | n/a | -1.13M | n/a | -3.26M | -2M | -4.23M | -2.96M |
Growth CapEx | n/a | n/a | n/a | n/a | -70K | -128K | -288K | -136K | -366K | -214K | -80K | -331K | -147K | -592.21K | n/a | n/a | -104K | -50.9K | -375K | n/a | n/a | -520.24K | n/a |
Owner Earnings | 32.27M | -12.77M | 1.71M | 10.44M | 32.03M | 11.74M | 232K | 9.33M | 9.74M | -13.22M | -7.65M | 11.58M | 3.53M | -9.8M | -23M | 4.92M | 12.62M | 2.87M | 609K | 12.2M | 1.21M | 5.13M | 4.1M |
Add to Watchlist
Select watchlists to add or remove PHAR